Website profile

Tradingview

Where the world charts, chats and trades markets. We're a supercharged super-charting platform and social network for traders and investors. Free to sign up.

  • 234,771articles · 365d
  • 2+ hour agolatest article
  • Sep 14, 2025earliest in window
  • 93%with images · 64 videos
  • 137avg words
articles per day
Categories
  • Economy, Business & Finance 223,981
  • Finance & Business 218,014
  • News 122,501
  • Finance 64,062
  • Business & Industrial 28,021
  • Industrial 5,224
  • Health & Wellness 4,213
  • Computers & Electronics 2,618

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > news > zacks:c7dd0fbf0094b:0-reasons-to-retain-alignment-healthcare-stock-in-your-portfolio-for-now

Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now

1+ mon, 3+ week ago   (448+ words) In the past year, this Zacks Rank #3 (Hold) company’s shares have gained 56.3% compared with the industry’s 15.2% growth. The S&P 500 composite has risen 23.8% in the same period. The leading medtech company has a market capitalization of $4.38 billion. Alignment Healthcare beat…...

TradingView
tradingview.com > news > zacks:ce7a1c826094b:0-alignment-healthcare-outlook-as-ma-growth-fuels-margin-gains-in-2026

Alignment Healthcare Outlook as MA Growth Fuels Margin Gains in 2026

2+ mon, 6+ day ago   (768+ words) Alignment Healthcare, Inc. ALHC is drawing investor attention as Medicare Advantage growth, quality ratings and operating leverage begin to show up in profitability. The company reported first-quarter 2026 earnings of 5 cents per share, compared with a year-ago loss. The setup is…...

TradingView
tradingview.com > news > tradingview:0a98eee62e33f:0-humana-inc-stock-12-month-price-target-raised-to-283-54-implies-13-downside

Humana Inc. Stock 12‑Month Price Target Raised to $283.54, Implies 13% Downside

3+ mon, 1+ week ago   (116+ words) TradingView Humana Inc. Stock 12‑Month Price Target Raised to $283.54, Implies 13% Downside - According to estimates from 24 analysts, Humana Inc. stock's average price target has risen from $279.17 to $283.54, with forecasts ranging from $195 to $441 per share - Based on the Jun. 3 closing price, the…...

TradingView
tradingview.com > news > tradingview:f9bf8f835fc8d:0-selectis-health-inc-1q-2026-revenue-7-29m-eps-1-9-10-q-summary

SELECTIS HEALTH, INC. 1Q 2026: Revenue $7.29M, EPS $1.9— 10-Q Summary

3+ mon, 3+ week ago   (197+ words) TradingView SELECTIS HEALTH, INC. 1Q 2026: Revenue $7.29M, EPS $1.9— 10-Q Summary SELECTIS HEALTH, INC. reported first-quarter 2026 results with revenue of $7.29M and net income of $6.52M attributable to common stockholders; diluted earnings per share were $1.9, driven largely by gains on recent facility sales despite a…...

TradingView
tradingview.com > news > tradingview:e2ec593a39411:0-humana-inc-stock-12-month-price-target-raised-to-246-46-implies-18-downside

Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside

3+ mon, 4+ week ago   (116+ words) TradingView Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside - According to estimates from 24 analysts, Humana Inc. stock's average price target has risen from $243.5 to $246.46, with forecasts ranging from $180 to $290 per share - Based on the May 14 closing price, the…...

TradingView
tradingview.com > news > marketbeat:462ed5a12094b:0-cvrx-q1-earnings-call-highlights

CVRx Q1 Earnings Call Highlights

4+ mon, 1+ day ago   (1138+ words) CVRx CVRX reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end of its guidance range, executives said on the company’s earnings call. President and…...